-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Telomir Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2023 to Q3 2024.
- Telomir Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.2 USD/shares, a 233% decline year-over-year.
- Telomir Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.82 USD/shares.
- Telomir Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -0.48 USD/shares, a 1500% decline from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)